Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 24, 2015 9:37 PM ET

Biotechnology

Company Overview of Agouron Pharmaceuticals, Inc.

Executive Profile

Michael D. Varney Ph.D.

Head of Genentech Research & Early Development, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
56--

Background

Mr. Michael D. Varney, also known as Mike, Ph.D. has been Head of Genentech Research & Early Development at Roche Holding AG since January 1, 2015. Mr. Varney serves as Executive Vice President of Genentech Research & Early Development of Genentech Inc. He served as Head of Small Molecule Drug Discovery and Co-Head of Genentech Research at Roche Holding AG until December 31, 2014. Mr. Varney served as Senior Vice President of Small Molecule Drug Discovery at Genentech ...

Corporate Headquarters

10777 Science Center Drive
San Diego, California 92121-1111

United States

Phone: 858-622-3000
Fax: 858-678-8267

Board Members Memberships

Director

Education

Post-Doctoral Training
Columbia University
BS
University of California-Los Angeles
PhD
California Institute of Technology

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Joseph Jimenez MBAChief Executive Officer
Novartis AG
$6.1M
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Agouron Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.